Abbott Laboratories
$97.55Change from previous close: −1.30%Absolute change: −$1.28
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 44,328 | 41,950 | 40,109 | 43,653 | 43,075 |
| Cost of revenue | 19,210 | 18,644 | 17,919 | 19,083 | 18,080 |
| Gross profit | 25,118 | 23,306 | 22,190 | 24,570 | 24,995 |
| Selling, general and administrative | 11,630 | 11,109 | 10,385 | 10,703 | 11,006 |
| Research and development | 2,889 | 2,823 | 2,619 | 2,741 | 2,738 |
| Operating income | 8,917 | 7,496 | 7,220 | 9,113 | 9,204 |
| EBIT | 8,917 | 7,496 | 7,220 | 9,113 | 9,204 |
| EBITDA | 12,033 | 10,714 | 10,463 | 12,380 | 12,742 |
| Interest expense | 493 | 559 | 637 | 558 | 533 |
| Pre-tax income | 8,466 | 7,013 | 6,664 | 8,306 | 8,211 |
| Income tax | 1,942 | -6,389 | 941 | 1,373 | 1,140 |
| Net income | 6,524 | 13,402 | 5,723 | 6,933 | 7,071 |
| Net income to common shareholders | 6,500 | 13,400 | 5,700 | 6,905 | 7,042 |
| Basic EPS | 3.73 | 7.70 | 3.28 | 3.94 | 3.97 |
| Diluted EPS | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 |
| Average shares (basic) | 1,741 | 1,740 | 1,740 | 1,753 | 1,775 |
| Average shares (diluted) | 1,748 | 1,748 | 1,749 | 1,764 | 1,789 |
| Dividend per share | 2.40 | 2.24 | 2.08 | 1.92 | 1.82 |